Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CELGENE CORP [US]”

5 pharma patents match "CELGENE CORP [US]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "CELGENE CORP [US]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “CELGENE CORP [US]” · 30,257 patents in full index Clear search

  1. EP 3539539

    TABLETTENFORMULIERUNGEN AUS (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLIN-1,3-DION

    CELGENE CORP [US] · Granted Sep 18, 2019 · Expires Sep 13, 2039

    granted

  2. EP 3320902

    VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN MIT ISOINDOLINVERBINDUNGEN

    CELGENE CORP [US] · Granted May 16, 2018 · Expires May 11, 2038

    granted

  3. MX 2015008685

    TREATMENT OF PSORIATIC ARTHRITIS USING APREMILAST.

    CELGENE CORP [US] · Granted Oct 5, 2015 · Expires Sep 30, 2035

    granted

  4. EP 2651400

    ORALE RETARD-DARREICHUNGSFORMEN VON SCHWER LÖSLICHEN ARZNEIMITTELN UND IHRE VERWENDUNG

    CELGENE CORP [US] · Granted Oct 23, 2013 · Expires Oct 18, 2033

    granted

  5. EP 2555769

    VERFAHREN ZUR BEHANDLUNG VON VIRALEN ATEMWEGSINFEKTIONEN

    CELGENE CORP [US] · Granted Feb 13, 2013 · Expires Feb 8, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.